Decrease of total serum-bilirubin concentration in newborn infants after phenobarbitone treatment.
D001663:Bilirubin / Q000097:blood* / Q000378:metabolism; D005260:Female; D006801:Humans; D006932:Hyperbilirubinemia / Q000188:drug therapy*; D007231:Infant, Newborn; D007567:Jaundice, Neonatal / Q000188:drug therapy* / Q000517:prevention & control; D008099:Liver / Q000187:drug effects; D008431:Maternal-Fetal Exchange; D008861:Microsomes / Q000187:drug effects; D010634:Phenobarbital / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D011247:Pregnancy
D001663:Bilirubin; D010634:Phenobarbital